Rosacea or photodamaged skin? Use of brimonidine gel in differentiating erythema in the two conditions.Australas J Dermatol. 2017 Feb; 58(1):63-64.AJ
Abstract
In this case report, we detail the response of a 37-year-old Caucasian man with an overlap of erythematotelangiectatic rosacea and telangiectatic photoaging to brimonidine tartrate gel. With the application of brimonidine only on half of his face, skin analysis images, clinician's and patient's assessment showed that there was significant improvement in the erythema. This case has lent insight into how brimonidine can be used to assess the extent of photoaging by eliminating the erythema of rosacea to some degree. We propose that it can be used as a non-invasive test to differentiate between the two conditions, sparing patients from skin biopsies and molecular analysis.
Links
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
26763464
Citation
Oon, Hazel H., and Ziying Vanessa Lim. "Rosacea or Photodamaged Skin? Use of Brimonidine Gel in Differentiating Erythema in the Two Conditions." The Australasian Journal of Dermatology, vol. 58, no. 1, 2017, pp. 63-64.
Oon HH, Lim ZV. Rosacea or photodamaged skin? Use of brimonidine gel in differentiating erythema in the two conditions. Australas J Dermatol. 2017;58(1):63-64.
Oon, H. H., & Lim, Z. V. (2017). Rosacea or photodamaged skin? Use of brimonidine gel in differentiating erythema in the two conditions. The Australasian Journal of Dermatology, 58(1), 63-64. https://doi.org/10.1111/ajd.12430
Oon HH, Lim ZV. Rosacea or Photodamaged Skin? Use of Brimonidine Gel in Differentiating Erythema in the Two Conditions. Australas J Dermatol. 2017;58(1):63-64. PubMed PMID: 26763464.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Rosacea or photodamaged skin? Use of brimonidine gel in differentiating erythema in the two conditions.
AU - Oon,Hazel H,
AU - Lim,Ziying Vanessa,
Y1 - 2016/01/13/
PY - 2015/08/27/received
PY - 2015/10/28/accepted
PY - 2016/1/15/pubmed
PY - 2017/10/12/medline
PY - 2016/1/15/entrez
KW - brimonidine tartrate
KW - erythematotelangiectatic rosacea
KW - telangiectatic photoaging
SP - 63
EP - 64
JF - The Australasian journal of dermatology
JO - Australas J Dermatol
VL - 58
IS - 1
N2 - In this case report, we detail the response of a 37-year-old Caucasian man with an overlap of erythematotelangiectatic rosacea and telangiectatic photoaging to brimonidine tartrate gel. With the application of brimonidine only on half of his face, skin analysis images, clinician's and patient's assessment showed that there was significant improvement in the erythema. This case has lent insight into how brimonidine can be used to assess the extent of photoaging by eliminating the erythema of rosacea to some degree. We propose that it can be used as a non-invasive test to differentiate between the two conditions, sparing patients from skin biopsies and molecular analysis.
SN - 1440-0960
UR - https://www.unboundmedicine.com/medline/citation/26763464/Rosacea_or_photodamaged_skin_Use_of_brimonidine_gel_in_differentiating_erythema_in_the_two_conditions_
DB - PRIME
DP - Unbound Medicine
ER -